Fibromyalgia

Your daily dose of the clinical news you may have missed.

The US FDA approved Tonmya, a groundbreaking treatment for fibromyalgia, offering hope to millions experiencing chronic pain and sleep issues.

NX-102 SL is a non-opioid, centrally acting analgesic, granted Fast Track designation by FDA.

If approved, the nonopioid, centrally acting analgesic would be the first in a new class of medications for fibromyalgia in more than 15 years, Tonix said.

Your daily dose of clinical news you may have missed.

Patients with rheumatoid arthritis and fibromyalgia were at the greatest risk of transitioning to long-term opioid use 1 year after a first prescription, a new study found.

In a study of adults with pain in at least 1 body region, those with fibromyalgia had significantly greater odds of acknowledging pain-related addiction exacerbations.

Is acupuncture effective in reducing pain? Can exercise help patients with fibromyalgia sleep better? New systematic review and meta-analysis provides insight.

SAMPLE: Based on current research, what is the prevalence of fibromyalgia in the general population? Plus 11 more questions on fibromyalgia and chronic pain.

Chronic pain affects more Americans than diabetes mellitus, heart disease, and cancer combined. Here are some facts and figures about pain for you to consider.